rf-fullcolor.png

 

December 1, 2014
by Alexander Gaffney, RAC

Hacking Group Targets Regulatory Professionals, Seeking Insider Information

Regulatory professionals, watch out: A group of hackers is targeting pharmaceutical and medical device companies, and eyeing regulatory professionals as a way past corporate firewalls.

The New York Times is reporting that a group of investment-oriented hackers has been targeting more than 100 companies—"the vast majority publicly traded healthcare or pharmaceutical companies"—in a bid to gain a "market edge."

The attacks are remarkable, The Times noted, in that the hackers seem to correspond in perfect English and have a deep understanding of the regulatory language of the healthcare sectors they are targeting.

"Different groups of victims — frequently including top-level executives; legal counsel; regulatory, risk and compliance officers; researchers; and scientists — are sent different emails," Times reporter Nicole Perlroth wrote, citing the research of the security company FireEye, which first uncovered the hacking network now called "Fin4."

The hackers appear to be after as-yet undisclosed regulatory information, including product safety reports, investigation results and audits.

The Times report the hacking group accesses this information by prompting its victims to login to a fake email system "designed to steal the victim's credentials." The group then quietly pores through the user's email account, looking for valuable information.

 

New York Times report

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.